Huntington’s disease research news. In plain language. Written by scientists. For the global HD community.

Are you looking for our logo? You can download our logo and get information about how to use it on our sharing page

Dr Mark Guttman, MD, FRCPC

Oversight Committee — External Medical Advisor

Markham, Canada

Mark is a movement disorder neurologist with a special interest in Huntington’s disease. In addition to providing patient care Mark is involved in clinical research with HD as part of a number of studies. Current studies include PREDICT HD which is the largest observational study that follows premanifest HD subjects to understand their earliest changes, FuRST pHD which hopes to develop a rating scale to measure the earliest symptoms, 2CARE which is to evaluated in early symptomatic HD subjects have a slower rate of progression with CoEnzyme Q-10. Mark is interested in developing disease modifying strategies to help HD patients.